Article
Myeloid cell 5-lipoxygenase activating protein modulates the response to vascular injury.
Circulation research - 1 Feb 2013
Yu Zhou, Ricciotti Emanuela, Miwa Takashi, Liu Shulin, Ihida-Stansbury Kaori, Landesberg Gavin, Jones Peter L, Scalia Rosario, Song Wen-Chao, Assoian Richard K, FitzGerald Garret A
Abstract excerpt
RATIONALE: Human genetics have implicated the 5-lipoxygenase enzyme in the pathogenesis of cardiovascular disease, and an inhibitor of the 5-lipoxygenase activating protein (FLAP) is in clinical development for asthma. OBJECTIVE: Here we determined whether FLAP deletion modifies the response to vascular injury. METHODS AND RESULTS: Vascular remodeling was characterized 4 weeks after femoral arterial injury in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
